Uterine Cervical Neoplasms: all 1,927 studies
Page 5 of 20. Open to participants first (576), then studies with results posted, then the rest; newest registration first within each.
- Estimation of Tumor Response With Linac MRI-guided Adaptive Radiotherapy for Locally Advanced Cervical CancerRecruitingNCT05942742
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2
- MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)RecruitingNCT05937958
- Immunotherapy-related CRP Kinetics in Metastatic Gynecological MalignanciesRecruitingNCT05914974
- A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsRecruitingNCT05914116Phase 1/2
- MR-Only Based Adaptive External Beam Radiation Therapy of Cervical Cancer on Ethos Therapy: Feasibility StudyRecruitingNCT05909111Not applicable
- Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical CancerRecruitingNCT05904977
- The Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therapy.RecruitingNCT05902390Not applicable
- Real-world Study of Serplulimab in 2L and Above Treatment of Cervical CancerRecruitingNCT05883670
- Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical CancerNot yet recruitingNCT05879796
- Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)RecruitingNCT05872724Phase 2
- Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical CancerRecruitingNCT05863260
- Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)RecruitingNCT05855941
- mSaada: A Mobile Health ToolRecruitingNCT05848557Not applicable
- A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical CancerRecruitingNCT05838521Phase 2
- Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint InhibitorsNot yet recruitingNCT05824494Phase 2
- Cadonilimab Plus Anlotinib for R/M/P Cervical CancerRecruitingNCT05817214Phase 2
- Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical CancerRecruitingNCT05808933
- Hyperpolarized 13C MRI for Cancer ImmunotherapyNot yet recruitingNCT05805358Phase 2
- A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological MalignanciesRecruitingNCT05803018Phase 1/2
- Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical CancerNot yet recruitingNCT05799469Phase 2
- Early Intervention to Prevent Lower Limb Lymphedema of Gynecological MalignancyRecruitingNCT05793749Not applicable
- Discovering Factors in Cervical Cancer Patients' Clinical Trial ExperiencesNot yet recruitingNCT05789628
- Role of Liquid Biopsies in HPV-associated Cancer Treatment MonitoringRecruitingNCT05774561
- Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical CancerNot yet recruitingNCT05772377Phase 2
- First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsRecruitingNCT05768139Phase 1/2
- Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical CancerRecruitingNCT05764044Phase 3
- PROton Therapy for Post Surgical Treatment of GYNecologic CancerRecruitingNCT05758688Phase 2
- The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.RecruitingNCT05749887Not applicable
- Adherence and Compliance to ERAS in Gynecological SurgeryRecruitingNCT05738902
- Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical CancerRecruitingNCT05735145Phase 3
- Screening Triage and Risk StratificationRecruitingNCT05727228
- Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)Not yet recruitingNCT05715840Phase 3
- Radiomics-based Malnutrition for Cervical Cancer.RecruitingNCT05709769
- Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical CancerRecruitingNCT05701735Not applicable
- Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical CancerRecruitingNCT05690906Phase 2
- Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical CancerRecruitingNCT05687851Phase 2
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersRecruitingNCT05686226Phase 2
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersRecruitingNCT05639972Phase 1/2
- A Cohort Study of Uterine MalignanciesRecruitingNCT05635123
- Plan of the Day RadiotherapyRecruitingNCT05634681Not applicable
- Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical CancerRecruitingNCT05606263Phase 2
- Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic CancersRecruitingNCT05606133Not applicable
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical CancerRecruitingNCT05588219Phase 2
- PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical CancerRecruitingNCT05581121Phase 3
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)RecruitingNCT05579366Phase 1/2
- A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01RecruitingNCT05570422Phase 1
- Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive WomenRecruitingNCT05570331
- Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical CancerRecruitingNCT05554276Phase 2
- Adaptation and Implementation of a Patient Navigation Program for Cervical Cancer Screening Across Contexts in SenegalRecruitingNCT05544084Not applicable
- An Exploratory Study of Using Magnetic Resonance Prognostic Imaging Markers for Radiotherapy In Patients With Cervix Cancer (EMPIRIC Study)RecruitingNCT05532930
- Detection of Minimal Residual Disease Based on HPV ctDNA in Cervical CancerRecruitingNCT05531981
- HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved IndividualsEnrolling by invitationNCT05528237Not applicable
- Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination InterventionEnrolling by invitationNCT05524480Not applicable
- Glutaminase Inhibition and Chemoradiation in Advanced Cervical CancerNot yet recruitingNCT05521997Phase 2
- A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsRecruitingNCT05518253Phase 1
- A Phase 2 Study of Avutometinib (VS-6766) Plus DefactinibRecruitingNCT05512208Phase 2
- Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical CancerRecruitingNCT05511623Phase 2
- Nivolumab-ipilimumab and Chemoradiation for Cervical CancerRecruitingNCT05492123Phase 2
- KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerRecruitingNCT05483491Phase 1
- Study of C-TIL052A Cell Therapy in Advanced Cervical CancerRecruitingNCT05475847Phase 1
- Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)RecruitingNCT05475171Phase 2
- Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal AblationRecruitingNCT05472311Not applicable
- A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-TRecruitingNCT05468190Phase 1
- QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical CancerRecruitingNCT05446883Phase 3
- A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical CancerNot yet recruitingNCT05444374Phase 2
- Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerRecruitingNCT05437692Phase 2
- Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain ManagementRecruitingNCT05427058Not applicable
- Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICrRecruitingNCT05421650Not applicable
- A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsRecruitingNCT05420545Phase 1
- Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South AfricaRecruitingNCT05413798Not applicable
- PROTECT: On-line Adaptive Proton Therapy for Cervical CancerRecruitingNCT05406856Not applicable
- Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer PatientsRecruitingNCT05401175Not applicable
- HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic AcidRecruitingNCT05385406Not applicable
- Rice Technologies for Cervical Cancer Screening and DiagnosisRecruitingNCT05372484Not applicable
- Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV VaccineRecruitingNCT05371353
- Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III TrialRecruitingNCT05367206Phase 3
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
- A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)RecruitingNCT05334706Phase 4
- PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical CancerRecruitingNCT05311566Phase 2
- Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening ProgrammeRecruitingNCT05286034Not applicable
- Improving Diagnostics in Cervical DysplasiaRecruitingNCT05283421Not applicable
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsRecruitingNCT05283330Phase 1
- Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer PatientsRecruitingNCT05277688Phase 3
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
- Retrospective Study of BrachytherapyRecruitingNCT05242861
- Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in ScreeningEnrolling by invitationNCT05231993Not applicable
- HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapyNot yet recruitingNCT05210270Phase 1/2
- Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical CancerRecruitingNCT05189028Phase 3
- Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical CancerRecruitingNCT05173272Phase 3
- Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in EthiopiaRecruitingNCT05125380Not applicable
- A Study of NX-1607 in Adults With Advanced MalignanciesRecruitingNCT05107674Phase 1
- Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix CancerRecruitingNCT05102240
- Clinical Study of Indocyanine Green Displaying Pelvic Nerve in Radical Operation of Cervical CancerRecruitingNCT05087264Early Phase 1
- A Beta-only IL-2 ImmunoTherapY StudyRecruitingNCT05086692Phase 1/2
- Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical CancerRecruitingNCT05084677Phase 2
- Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical CancerRecruitingNCT05051722
- Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 YearsRecruitingNCT05027776Phase 3
- Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical CancerNot yet recruitingNCT04999696Not applicable